ArticleJournal of drug assessment2019

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma.

Maria Lorenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.